Changing paradigms in the frequency and management of canine compound uroliths.
This article discusses the composition, formation, and treatment of canine compound uroliths and the importance of recognizing the unique causal factors that may be present in each individual patient. After first giving a detailed analysis of what compound uroliths are and how they form, the authors give examples and data from canine uroliths submitted between 1981 and 2007. Finally, the article discusses the importance of this data when formulating management strategies for individual patients to either dissolve existing stones or minimize urolith recurrence.
Ulrich
Lisa K
LK
Veterinary Clinical Sciences Department, Minnesota Urolith Center, College of Veterinary Medicine, University of Minnesota, 1352 Boyd Avenue, St. Paul, MN 55108, USA. unger003@umn.edu
Osborne
Carl A
CA
Cokley
Amy
A
Lulich
Jody P
JP
D000818:Animals; D001947:Breeding; D002129:Calcium Oxalate / Q000737:chemistry; D004283:Dog Diseases / Q000453:epidemiology* / Q000209:etiology / Q000517:prevention & control; D004285:Dogs; D005260:Female; D017616:Magnesium Compounds / Q000737:chemistry; D008297:Male; D010710:Phosphates / Q000737:chemistry; D055502:Secondary Prevention; D000069877:Struvite; D014527:Uric Acid / Q000737:chemistry; D014545:Urinary Calculi / Q000737:chemistry / Q000453:epidemiology / Q000662:veterinary*
D017616:Magnesium Compounds; D010710:Phosphates; D002129:Calcium Oxalate; D014527:Uric Acid; D000069877:Struvite